Health Economics Unit, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Perth, Australia.
Glob Health Action. 2021 Jan 1;14(1):1972561. doi: 10.1080/16549716.2021.1972561.
Common mental disorders (CMDs) are highly prevalent conditions that constitute a major public health and economic burden on society in low- and middle-income countries (LMICs). Despite the increased demand for economic evidence to support resource allocation for scaled-up implementation of mental health services in these contexts, economic evaluations of psychological treatments for CMDs remain scarce.
The proposed systematic review aims to synthesize findings on methods and outcomes of economic evaluations of psychological treatments for CMDs in LMICs and appraise quality.
We will identify, select, and extract data from published economic evaluations of psychological interventions for CMDs conducted in LMICs. We will search bibliographic databases (PubMed, EMBASE, CINAHL, Web of Science, EconLit, PsycINFO, Africa-Wide Information, Cochrane library, Centre for Reviews and Dissemination (CRD), Cost Effectiveness Analysis (CEA) Registry), and the African Journals Online (AJOL) and Google Scholar platforms. Only full economic evaluations (Cost-Effectiveness Analysis (CEA), Cost-Utility Analysis (CUA), Cost-Consequence Analysis (CCA), or Cost-Benefit Analysis (CBA)) of psychological treatments for CMDs (defined as depressive, anxiety, and substance use disorders) conducted in LMICs will be included. There will be no restrictions based on date of publication, perspective, follow-up duration or sample size. Data extraction will be guided by the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist.
The results presented will be examined using a narrative synthesis approach. The quality of included studies will be assessed using the Drummond & Jefferson checklist.
The fledgling evidence base in this area provides an opportunity to promote improved economic evaluation methods in line with repeated calls for economic evidence alongside effectiveness evidence in these settings. A rigorously developed economic evaluation evidence base will support resource allocation decisions for scaled up implementation of psychological interventions in LMIC settings.
PROSPERO CRD42020185277.
常见精神障碍(CMD)是一种高发疾病,在中低收入国家(LMIC)给社会带来了重大的公共卫生和经济负担。尽管这些国家对支持扩大精神卫生服务所需资源分配的经济证据的需求不断增加,但针对 CMD 的心理治疗的经济评估仍然很少。
本系统综述旨在综合 LMIC 中针对 CMD 的心理治疗的经济评估方法和结果,并对其质量进行评估。
我们将从在 LMIC 中进行的针对 CMD 的心理干预的已发表的经济评估中识别、选择和提取数据。我们将搜索文献数据库(PubMed、EMBASE、CINAHL、Web of Science、EconLit、PsycINFO、Africa-Wide Information、Cochrane 图书馆、中心评价与传播部(CRD)、成本效益分析(CEA)登记处)和非洲期刊在线(AJOL)和谷歌学术平台。仅将包括针对 CMD(定义为抑郁、焦虑和物质使用障碍)的心理治疗的完整经济评估(成本效益分析(CEA)、成本效用分析(CUA)、成本后果分析(CCA)或成本效益分析(CBA))纳入研究。将不会根据出版物日期、视角、随访时间或样本量进行限制。数据提取将遵循健康经济评估报告标准(CHEERS)清单进行。
将使用叙述性综合方法检查呈现的结果。将使用 Drummond 和 Jefferson 清单评估纳入研究的质量。
该领域刚刚出现的证据基础为在这些环境中提供了一个机会,可以根据反复呼吁在这些环境中提供有效性证据的同时提供经济证据,从而促进经济评估方法的改进。一个经过严格制定的经济评估证据基础将支持资源分配决策,以扩大在 LMIC 环境中实施心理干预的规模。
PROSPERO CRD42020185277。